Tm. Tallab et al., CUTANEOUS LEISHMANIASIS - SCHEDULES FOR INTRALESIONAL TREATMENT WITH SODIUM STIBOGLUCONATE, International journal of dermatology, 35(8), 1996, pp. 594-597
Background. Various therapeutic modalities have been used for treating
cutaneous leishmaniasis. Intralesional pentavalent antimonial injecti
on is one of the effective therapeutic modalities. In this study, the
efficacy of three different intralesional schedules with sodium stibog
luconate have been investigated.Methods. Ninety-six patients with 129
lesions were entered into the study, all with confirmed diagnosis of c
utaneous leishmaniasis. The lesions were treated with three different
schedules, including daily, alternate day, and weekly interlesional in
jections of sodium stibogluconate. The clinical response was then comp
ared to arrive at the most effective schedule. Results. The clinical r
esponses (complete and partial cure) were 67%, 97%, and 91% for the da
ily, alternate-day, and weekly schedules, respectively. Lesions with e
ither partial cure or failure of treatment were injected weekly with t
he same medication until complete cure had been achieved. The final ov
erall success rate of complete cure was 99.2%. Conclusions. Alternate
day or weekly intralesional treatment of cutaneous leishmaniasis with
sodium stibogluconate are more effective than daily treatments.